(6R)-5-benzyl-6-methyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclobutylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,2-difluoropropyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-3-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-5-methylphenyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
C169H183F4N27O18 — CID 158428553
Data last refreshed: (MolForge compound catalog, from PubChem)
About (6R)-5-benzyl-6-methyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclobutylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,2-difluoropropyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-3-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-5-methylphenyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
(6R)-5-benzyl-6-methyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclobutylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,2-difluoropropyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-3-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-5-methylphenyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one (PubChem CID 158428553) has the molecular formula C169H183F4N27O18 and a molecular weight of 2956.49 g/mol. Its IUPAC name is (6R)-5-benzyl-6-methyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclobutylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,2-difluoropropyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-3-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-5-methylphenyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one.
Molecular Properties
| Compound Name | (6R)-5-benzyl-6-methyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclobutylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,2-difluoropropyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-3-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-5-methylphenyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one |
|---|---|
| PubChem CID | 158428553 |
| Molecular Formula | C169H183F4N27O18 |
| Molecular Weight | 2956.49 g/mol |
| Exact Mass | 2954.42 |
| IUPAC Name | (6R)-5-benzyl-6-methyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclobutylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(2,2-difluoropropyl)-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-3-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-fluoro-5-methylphenyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylcyclobutyl)methyl]-2-phenylmethoxy-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one |
| SMILES | CC(F)(F)CN1CCn2nc(OCc3ccccc3)cc2C1=O.CC1(CN2CCn3nc(OCc4ccccc4)cc3C2=O)CCC1.CC1(F)CC(CN2CCn3nc(OCc4ccccc4)cc3C2=O)C1.C[C@@H]1Cn2nc(OCc3ccccc3)cc2C(=O)N1Cc1ccccc1.Cc1cc(F)cc(CN2CCn3nc(OCc4ccccc4)cc3C2=O)c1.O=C1c2cc(OCc3ccccc3)nn2CCCN1CC1CC1.O=C1c2cc(OCc3ccccc3)nn2CCN1CC1CC1.O=C1c2cc(OCc3ccccc3)nn2CCN1CC1CCC1.O=C1c2cc(OCc3ccccc3)nn2CCN1Cc1ccccc1 |
| InChI | InChI=1S/C21H20FN3O2.C21H21N3O2.C20H19N3O2.C19H22FN3O2.C19H23N3O2.2C18H21N3O2.C17H19N3O2.C16H17F2N3O2/c1-15-9-17(11-18(22)10-15)13-24-7-8-25-19(21(24)26)12-20(23-25)27-14-16-5-3-2-4-6-16;1-16-13-24-19(21(25)23(16)14-17-8-4-2-5-9-17)12-20(22-24)26-15-18-10-6-3-7-11-18;24-20-18-13-19(25-15-17-9-5-2-6-10-17)21-23(18)12-11-22(20)14-16-7-3-1-4-8-16;1-19(20)10-15(11-19)12-22-7-8-23-16(18(22)24)9-17(21-23)25-13-14-5-3-2-4-6-14;1-19(8-5-9-19)14-21-10-11-22-16(18(21)23)12-17(20-22)24-13-15-6-3-2-4-7-15;22-18-16-11-17(23-13-15-5-2-1-3-6-15)19-21(16)10-4-9-20(18)12-14-7-8-14;22-18-16-11-17(23-13-15-5-2-1-3-6-15)19-21(16)10-9-20(18)12-14-7-4-8-14;21-17-15-10-16(22-12-14-4-2-1-3-5-14)18-20(15)9-8-19(17)11-13-6-7-13;1-16(17,18)11-20-7-8-21-13(15(20)22)9-14(19-21)23-10-12-5-3-2-4-6-12/h2-6,9-12H,7-8,13-14H2,1H3;2-12,16H,13-15H2,1H3;1-10,13H,11-12,14-15H2;2-6,9,15H,7-8,10-13H2,1H3;2-4,6-7,12H,5,8-11,13-14H2,1H3;2*1-3,5-6,11,14H,4,7-10,12-13H2;1-5,10,13H,6-9,11-12H2;2-6,9H,7-8,10-11H2,1H3/t;16-;;;;;;;/m.1......./s1 |
| InChIKey | HBJCQEUJTFPLJY-RXCANMIXSA-N |
| XLogP | 26.69 |
| TPSA | 426.24 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 36 |
| Rotatable Bonds | 45 |
| Heavy Atoms | 218 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2956.49 |
| LogP ≤ 5 | 26.69 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 36 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158428553 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.